Work

Prophylaxis Against Cytomegalovirus Infections with Oral Maribavir in Allogeneic Stem Cell Transplant Recipients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.593.593

Authors: Drew Winston, Jo-Anne van Burik, Vinod Pullarkat, Genovefa Papanicolaou, Ravi Vij, Estil Vance, George Alangaden, Roy Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Carolyn Dougherty, Stephen Villano, Michael Boeckh

Institutions: Ronald Reagan UCLA Medical Center, UCLA Medical Center, University of Minnesota, City Of Hope National Medical Center, Memorial Sloan Kettering Cancer Center, Washington University in St. Louis, Baylor University Medical Center, Wayne State University, The University of Texas MD Anderson Cancer Center, University of Utah, Duke Medical Center, Tufts Medical Center, Fred Hutch Cancer Center

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2596792656

FWCI: 0.887

Cites:

Cited by: 5

Related to: 10